Johns Hopkins ABX Guide
Oxamniquine
INDICATIONS
FDA
FDA
- Not commercially available in the U.S.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Schistosomiasis (second-line agent for S. mansoni); praziquantel considered the drug of choice for schistosomiasis)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 15, 2022
Citation
Auwaerter, Paul G, and Paul A Pham. "Oxamniquine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540411/all/Oxamniquine.
Auwaerter PG, Pham PA. Oxamniquine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540411/all/Oxamniquine. Accessed November 17, 2024.
Auwaerter, P. G., & Pham, P. A. (2022). Oxamniquine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540411/all/Oxamniquine
Auwaerter PG, Pham PA. Oxamniquine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2024 November 17]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540411/all/Oxamniquine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oxamniquine
ID - 540411
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2022/10/15/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540411/all/Oxamniquine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
